European Union - English - EMA (European Medicines Agency)

mylan s.a.s. - lopinavir/ritonavir - hiv infections - antivirals for systemic use, - lopinavir/ritonavir is indicated in combination with other antiretroviral medicinal products for the treatment of human immunodeficiency virus (hiv-1) infected adults, adolescents and children above the age of 2 years.the choice of lopinavir/ritonavir to treat protease inhibitor experienced hiv-1 infected patients should be based on individual viral resistance testing and treatment history of patients.

European Union - English - EMA (European Medicines Agency)

mylan s.a.s. - lopinavir/ritonavir - hiv infections - antivirals for systemic use, - lopinavir/ritonavir is indicated in combination with other antiretroviral medicinal products for the treatment of human immunodeficiency virus (hiv-1) infected adults, adolescents and children above the age of 2 years.the choice of lopinavir/ritonavir to treat protease inhibitor experienced hiv-1 infected patients should be based on individual viral resistance testing and treatment history of patients.

Canada - English - Health Canada

abbvie corporation - lopinavir; ritonavir - solution - 400mg; 100mg - lopinavir 400mg; ritonavir 100mg - hiv protease inhibitors

Canada - English - Health Canada

abbvie corporation - lopinavir; ritonavir - tablet - 200mg; 50mg - lopinavir 200mg; ritonavir 50mg - hiv protease inhibitors

Canada - English - Health Canada

abbvie corporation - lopinavir; ritonavir - tablet - 100mg; 25mg - lopinavir 100mg; ritonavir 25mg - hiv protease inhibitors

Malta - English - Medicines Authority

accord healthcare limited - lopinavir; ritonavir - film-coated tablet - lopinavir 200 mg; ritonavir 50 mg - antivirals for systemic use

Singapore - English - HSA (Health Sciences Authority)

abbvie pte. ltd. - lopinavir; ritonavir - tablet, film coated - 100mg - lopinavir 100mg; ritonavir 25mg

Singapore - English - HSA (Health Sciences Authority)

abbvie pte. ltd. - lopinavir; ritonavir - tablet, film coated - 200.0mg - lopinavir 200.0mg; ritonavir 50.0mg

European Union - English - EMA (European Medicines Agency)

abbvie deutschland gmbh co. kg - lopinavir, ritonavir - hiv infections - antivirals for systemic use, protease inhibitors - kaletra is indicated in combination with other antiretroviral medicinal products for the treatment of human immunodeficiency virus (hiv-1) infected adults, adolescents and children aged from 14 days and older.the choice of kaletra to treat protease inhibitor experienced hiv-1 infected patients should be based on individual viral resistance testing and treatment history of patients.

Canada - English - Health Canada

abbvie corporation - lopinavir; ritonavir - capsule - 133.3mg; 33.3mg - lopinavir 133.3mg; ritonavir 33.3mg - hiv protease inhibitors